Short answer
Idexx Laboratories (IDXX) filed its Q2 2025 10-Q quarterly report on Aug 4, 2025 for the quarter ended Jun 30, 2025. Quarterly revenue was $1.1B (up 10.6% year over year) with net income of $294M.
Q2 2025 key financials · XBRL
- Revenue
- $1.1B
- +10.6% YoY · +11.1% QoQ
- Net income
- $294M
- +44.6% YoY · +21.1% QoQ
- Operating margin
- 33.6%
- Gross margin
- 62.6%
- EPS (diluted)
- $3.63
- +49.4% YoY · +22.6% QoQ
Source: XBRL data from the Idexx Laboratories (IDXX) Q2 2025 10-Q on SEC EDGAR. USD.
Idexx Laboratories Q2 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- No segment or product line performance data presented
- No cash flow or capital deployment changes detailed
- Focus on accounting estimates and assumptions, consistent with prior year disclosures
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Idexx Laboratories quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.